DOCSLIB.ORG

Lancet Laboratories Rwanda Ltd Pricelist

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lancet Laboratories Rwanda Ltd Pricelist Lancet Laboratories Rwanda Limited 1st Floor, Umuyenzi Plaza Airport Road, Kisimenti-Rimera Kigali - Rwanda [email protected] | www.lancet.co.rw Tel: 252 582 901 / +250784035660 LANCET LABORATORIES RWANDA LTD PRICELIST Turn-around-time Bill Code Description Standard Price (RwF) (TAT) 3764H000 A,B,O ANTIGENS 2 Hours 3 900 3794H005 A.A. AGGREGATIONS Contact Lab 20 900 3940I100 E.HISTOLITICA HAEMAGGLUT 5 Days 20 900 9049T000 ACETONE EXPOSURE, BLOOD Contact Lab 37 900 9046T000 ACETONE EXPOSURE,urine 9 Days 37 900 3940I100 ACETYL CHOLINESTERASE ERYTH 5 Days 16 900 4459R000 ACETYLCHOLINE RECEP AB 4 Weeks 167 900 4589H006 ACID PHOSPHATASE & TARTRATE Contact Lab 8 900 3995B001 ACID PHOSPHATASE (TOTAL) Contact Lab 12 900 4523E000 ACTH 7 Days 33 900 3726H000 ACTIVATED PROTEIN C RESISTANCE Contact Lab 41 900 4139B000 ADENOSINE DEAMINASE 5 Days 16 900 3795H000 ADP AGGREGATION 9 Days 20 900 3934I010 ADRENAL Ab 5 Days 24 900 4551R336 Adrenal stress profile R/O Contact Lab 209 900 3867M019 AEROB BLD CULT: GRAMSTAIN 7 Days 7 900 M000M003 AEROBIC/PAEDIATRIC BL CULT BD Contact Lab 28 900 3939R000 AGGLUTINATION TEST Contact Lab 16 900 3999B004 ALBUMIN FLUID 3 Hours 9 900 3999B001 ALBUMIN SERUM 3 Hours 6 900 4135B001 ALDOLASE SERUM 7 Days 10 900 4029B003 ALDOSTERONE-S 7 Days 20 900 4002B001 ALK. PHOS. ISOENZYMES 5 Days 16 900 4001B002 ALKALINE PHOSPHATASE 3 Hours 7 900 4005B000 ALPHA 1 ANTITRYPSIN 5 Days 9 900 4182R000 ALPHA 2 MACROGLOBULIN R/O 4 Weeks 20 900 4182B015 ALPHA-1-MICROGLOBULIN 5 Days 13 900 4522E001 ALPHA-FETOPROTEIN 5 Days 24 900 4374B100 ALUMINIUM URINE 10 Days 33 900 4493B002 AMIKACIN SERUM 5 Days 24 900 4040R000 AMINO ACID HCYS (QUANT) R/O Contact Lab 24 900 4266B001 AMINO ACID RANDOM URINE 5 Weeks 20 900 4265B001 AMINO ACIDS SERUM 4weeks 10 900 4003B001 AMMONIA BLOOD 5 Days 16 900 4307B001 AMMONIUM CHLORIDE LOAD 5 Days 37 900 4522E002 AMNIOTIC ALPHA-FETOPROTIEN 5 Days 20 900 4493B014 AMPHETAMINE URINE 5 Days 20 900 4515E001 AMYLASE FLUID 3 Days 9 900 4006B001 AMYLASE SERUM 3 Days 7 900 4197B001 AMYLASE URINE 3 Days 7 900 M000M004 ANAEORBIC BLOOD CULTURE BD 10 Days 28 900 1 of 32 Turn-around-time Bill Code Description Standard Price (RwF) (TAT) 3909M008 ANAEROBIC CULTURE - EYE 4 Days 28 900 3909M007 ANAEROBIC CULTURE (ENT) 4 Days 28 900 4496E003 ANDROSTENEDIONE 5 Days 24 900 4551I036 ANF SCREEN 5 Days 41 900 3934I200 ANF TITRE & PATTERN 5 Days 24 900 4136B001 ANGIOTENSIN CONV.ENZYME 5 Days 20 900 9050T000 ANHYDRIDE PHYTALIC ACID EXP U Contact Lab 28 900 9012T000 ANILINE EXPOSURE (U) 7 Weeks 41 900 4551L102 ANTE-NATAL SCREEN - BASIC 3 Days 24 900 4551L103 ANTE-NATAL SCREEN - FULL 3 Days 92 900 3934I206 ANTI ASIALO GM1 Contact Lab 24 900 3712H001 ANTI C Contact Lab 13 900 4371B001 ANTI CARDIOLIPIN (IgA/IgG/IgM) 3-4 Days 58 900 9999I002 Anti Cyelic Citrullunated Pept Contact Lab 28 900 3712H000 Anti D 4 Days 13 900 3712H006 ANTI Duffy Contact Lab 13 900 3712H002 ANTI E Contact Lab 13 900 3965I000 ANTI GAD ANTIBODIES 1 Week 49 900 3966I000 ANTI GAD ANTIBODIES 1 Week 49 900 3958I000 ANTI GAD/IA2 AB 1 Week 83 900 4613I000 ANTI GM2 7 Days 108 900 3712H005 ANTI Kell Contact Lab 13 900 3712H007 ANTI Kidd Contact Lab 13 900 3712H008 ANTI Lewis Contact Lab 13 900 3712H011 ANTI Lutheran Contact Lab 13 900 3712H009 ANTI MNS Contact Lab 13 900 3712H010 ANTI P Contact Lab 13 900 3735H000 ANTI THROMBIN III FUNC 3 Days 41 900 4551I035 ANTI THROMBIN III IMMUNO 5 Days 28 900 3948I202 ANTI-B2-GLYCOPROTEIN IGG Ab 5 Days 20 900 3887M014 ANTIBIOTIC SENS: PSEUDO Contact Lab 16 900 3934I002 ANTI-CENTROMERE Contact Lab 28 900 3728H001 ANTI-FACTOR Xa ACTIVITY 5 Days 79 900 3934I207 ANTI-GD1a 7 Days 28 900 3934I208 ANTI-GD1b 7 Days 28 900 3934I023 ANTI-GLOMERULAR BASEMENT MEM 7 Days 28 900 4613R000 ANTI-GM1 ANTIBODIES 7 Weeks 125 900 3934I209 ANTI-GQ1b 5 Days 24 900 4504I000 Anti-mullerian hormone 7 Days 62 900 3934I001 ANTI-NUCLEAR FACTOR SCREEN 5 Days 24 900 3948I203 ANTI-PROTHROMBIN IgG Ab 5 Days 20 900 3934I015 ANTI-RIBOSOMAL ANTIBODIES 7 Days 28 900 3948I007 ANTI-S.CEREVISIAE IgG AB 7 Days 20 900 3940B003 ANTI-STREP. DNAse B 3 Days 13 900 3735H005 ANTI-STREPTOLYSIN O 3 Days 13 900 4170B001 APOLIPOPROTEIN (A) 5 Days 20 900 4163B001 APOLIPOPROTEIN A1 SERUM 5 Days 16 900 4167B001 APOLIPOPROTEIN B SERUM 5 Days 16 900 3837H000 APTT (PATIENT) 3 Days 7 900 3934I024 AQUAPORIN-4 IFA 12 Days 28 900 4198B001 ARSENIC URINE 5 Weeks 33 900 4551L101 ARTHRITIS SCREEN 3 Days 45 900 2 of 32 Turn-around-time Bill Code Description Standard Price (RwF) (TAT) 4233R007 ARV NEVIRAPINE (AMPATH) 3 Weeks 49 900 4233R013 ARV RITONAVIR (AMPATH) 3 Weeks 49 900 3885M010 AURAMINE STAIN FOR AFB 7 Days 28 900 3973R001 AVIAN PRECIPITANTS (AMPATH) 7 Days 16 900 4172I004 B2 MICROGLOBULIN - CSF 5 Days 20 900 4172I003 B2 MICROGLOBULIN - SERUM 5 Days 20 900 4172I005 B2 MICROGLOBULIN - URINE 5 Days 20 900 3946I013 B2-MICROGLOBULIN (24HR) 5 Days 24 900 3940B002 B-ALLUMINIUM R/O Contact Lab 28 900 4493B029 BARBITURATES, URINE 5 Days 20 900 4493B028 BARBITURATES,SERUM 5 Days 20 900 4591I004 BARTONELLA HENSELAE IgG 12 Days 33 900 4591I005 BARTONELLA QUINTANA IgG 12 Days 33 900 4591I006 BARTONELLA QUINTANA IgG 12 Days 33 900 3764X000 BB BL GROUP RECIPIENT 3 Hours 4 900 3765X000 BB Rh D ANTIGEN RECIPIENT Contact Lab 4 900 9051T000 BENZENE EXPOSURE - BLOOD 20 Days 41 900 9047T000 BENZENE EXPOSURE (MUCONIC) (U) 20 Days 41 900 4493B021 BENZODIAZEPENES, SERUM 7 Days 20 900 4493B027 BENZODIAZEPENES, URINE 5 Days 20 900 9999R012 BETA GALACTOCEREBROSIDASE (RO) 7 Days 252 900 4182B017 BETA-TRANSFERRIN CSF 6 Days 16 900 4450E001 BHCG PREGNANCY SCREEN 3hcg 20 900 4450I001 BHCG PREGNANCY SCREEN (URINE) 1hour 7 900 4374R004 BICARBONATE FLUID 3 Days 6 900 4031B001 BICARBONATE TOTAL C02 SERUM 3 Days 5 900 3946I000 BILHARZIA AB (ELISA - IGM) 5 Days 24 900 3980R001 BILHARZIA Ag SERUM-CCA 5 Days 20 900 3980R000 BILHARZIA Ag URINE-CCA 5 Days 20 900 4377B001 BILIARY CALCULI Contact Lab 28 900 4009B002 BILIRUBIN (TOTAL) SERUM 3 Hrs 6 900 4010B001 BILIRUBIN CONJUGATED SERUM 3 Hrs 5 900 3998R003 BILLR WHITE CELL CYSTINE Contact Lab 113 900 4117R000 BILLR WHITE CELL PROT Contact Lab 4 900 9999M077 BLD CULT - AEROBIC 7 Days 28 900 9999M076 BLD CULT - ANAEROBIC ONLY 7 Days 28 900 3713H000 BLEEDING TIME 1hour 9 900 4007B000 Blood Arsenic Contact Lab 83 900 3881M009 BLOOD CULT: ZN Contact Lab 28 900 4551M049 BLOOD CULTURE - 2 BOTTLES 7 Days 49 900 4031B002 BLOOD CULTURE - PAED/AEROBIC 7 Days 28 900 4551M053 BLOOD CULTURE LYTIC 7 Weeks 7 900 4763D001 BLOOD DNA EXTRACTION Contact Lab 75 900 4763R000 BLOOD DNA HIV GENOTYPE R/O 7 Days 75 900 4076L000 BLOOD GAS PANEL 2 3 Days 24 900 3765H001 BLOOD GROUP 2 Hours 4 900 4146B001 BLOOD LEAD LEVEL 10 Days 33 900 3865H002 BLOOD PARASITES (THIN) 1day 7 900 4589H005 BONE MARROW ACID PHOSPHATASE 10 Days 12 900 4551H028 BONE MARROW ASPIRATE & TREPHIN 14 Days 83 900 3717H000 BONE MARROW CYTOLOGY 14 Days 28 900 3720H000 BONE MARROW TREPH BIOPSY 14 Days 66 900 3 of 32 Turn-around-time Bill Code Description Standard Price (RwF) (TAT) 4469B001 BONE SPECIFIC ALK. PHOSPHATASE 7 Days 24 900 3946I002 BORD. PERTUSSIS IGA ELISA 7 Days 20 900 3946I003 BORD. PERTUSSIS IGM ELISA 7 Days 24 900 4374T000 BROMIDE EXPOSURE BLOOD 16 Days 33 900 4551M050 BROMIDE EXPOSURE URINE 16 Days 33 900 4551M010 BRONCHIAL WASHING MCS 5 Days 28 900 3939I003 BRUC.ABORTUS/MELITENSIS Ab 5 Days 7 900 3948I003 BRUCELLA IGG ELISA 5 Days 20 900 3946I004 BRUCELLA IGM ELISA 5 Days 24 900 3715H000 BUFFY COAT 3 Days 28 900 4591V003 C PNEUMO ANTIGEN DETECTION 1 Week 41 900 3897V003 C PNEUMONIAE CULTURE 1 Week 20 900 4591V002 C PSITT ANTIGEN DETECTION 1 Week 41 900 4591V001 C TRACH ANTIGEN DETECTION 1 Week 41 900 3975I105 C.TRACHOMATIS IGG AB (IFA) 1 Week 20 900 3975I119 C.TRACHOMATIS IGM 1 Week 20 900 3772B005 C1 ESTERASE INHIBITOR SERUM 5 Days 20 900 3772B001 C3 - COMPLEMENT C3 SERUM 3 Days 13 900 3772B002 C4 - COMPLEMENT C4 SERUM 3 Days 13 900 4475E000 CA 724 12 Days 33 900 4374T001 CA125-S 6 Days 28 900 4468E001 CA153-S 6 Days 28 900 CA 19-9 4 Hours 23 000 4014B001 CADMIUM BLOOD 2-3 Weeks 37 900 4014B003 CADMIUM URINE 5 Days 37 900 4127B000 CAERULOPLASMIN SERUM 5 Days 12 900 4487R000 CALCITONIN 2-3 Weeks 30 900 4375B001 CALCIUM - FLUID 3 Days 5 900 4017B001 CALCIUM TOTAL SERUM 4 Hours 10 900 4205B001 CALCIUM URINE - 24HR 4 Hours 6 900 4205B002 CALCIUM URINE - RANDOM 4 Hours 6 900 4392B000 CALCULUS Chrystallography Contact Lab 28 900 3934I020 C-ANCA 3-5 Days 20 900 4551R340 Candida ab profile (Saliva R/O 3 Weeks 159 900 3882I001 CANDIDA ALBICANS AG 5-7 Days 24 900 3946I110 CANDIDA ALBICANS TOTAL AB Contact Lab 24 900 3722H000 CAPILLARY FRAGILITY 3 Days 3 900 4462E001 CARBAMAZAPINE (TEGRETOL),SERUM 3-5 Days 16 900 9067T000 CARBARYL EXPOSURE URINE 3-4 Weeks 41 900 4497B000 CARBOHYD.DEF.TRANSFERRIN 1-2 Weeks 41 900 9014T000 CARBON DISULPHIDE EXPOSURE (U) 3-4 Weeks 41 900 4078B002 CARBOXY-HAEMOGLOBIN 1-2 Weeks 16 900 4161B006 CARDIAC hs-TROPONIN T 3 Days 33 900 4551B004 CARDIAC PROFILE 2 Hours 62 900 4161B004 CARDIAC TROPONIN T 2 Hours 33 900 4019R000 CAROTENE SERUM 2-3 Days 37 900 4474I024 CAST ACETAMINOPHEN 7-9 Days 41 900 4474I093 CAST ALPHA LACTALBUMIN 4-5 Days 41 900 4474I081 CAST ALPHA-AMYLASE 4-5 Days 41 900 4474I071 CAST ALTERNARIA TENUIS 4-5 Days 41 900 4474I040 CAST AMARANTH 4-5 Days 41 900 4474I009 CAST AMOXYCILLIN 4-5 Days 41 900 4 of 32 Turn-around-time Bill Code Description Standard Price (RwF) (TAT) 4474I008 CAST AMPICILLIN 4-5 Days 41 900 4493B023 CAST ASPERGILLUS FUMIGATUS 4-5 Days 41 900 4474I025 CAST BAKER'S YEAST 4-5 Days 41 900 4474I029 CAST BARLEY 4-5 Days 41 900 4474I066 CAST BARLEY 4-5 Days 41 900 4474I019
Load more

Recommended publications
  • Brucellosis in Humans – Etiology, Diagnostics, Clinical Forms
    Annals of Agricultural and Environmental Medicine 2013, Vol 20, No 2, 233–238 REVIEW ARTICLE www.aaem.pl Brucellosis in humans – etiology, diagnostics, clinical forms Elżbieta Monika Galińska1, Jerzy Zagórski2 1 Department of Allergology and Environmental Hazards, Institute of Rural Health, Lublin, Poland 2 Department of Public Health, Institute of Rural Health, Lublin, Poland Galińska EM, Zagórski J. Brucellosis in humans – etiology, diagnostics, clinical forms. Ann Agric Environ Med. 2013; 20(2): 233–238. Abstract Brucellosis in humans is a zoonosis of greatly varied clinical image. It occurs on all inhabited continents. The course of the disease may be acute, sub-acute or chronic. The etiologic factors of brucellosis are small, aerobic Gram-negative rods of the genus Brucella, which currently contains ten species: B. abortus, B. suis, B. ovis, B. melitensis, B. canis, B. neotomae, B. pinnipedialis, B. ceti, B. microti and B. inopinata. In humans, the disease is caused mainly by: B. melitensis as the most pathogenic species, followed by B. suis, whereas B. abortus is considered as the mildest type of brucellosis. The natural reservoir of the germ and the source of infection in humans are infected domestic animals, primarily cattle, sheep, goats, as well as wild animals. Infection in humans occurs by penetration through damaged skin, conjunctiva, and more rarely via the alimentary route by the consumption of infected products. Especially exposed are: veterinarians, veterinary technicians, insemination service employees, zoo technicians,
    [Show full text]
  • (DNCB) and Respiratory Allergy in the Th2-Prone Brown Norway Rat C
    Available online at www.sciencedirect.com Toxicology 246 (2008) 213–221 The contact allergen dinitrochlorobenzene (DNCB) and respiratory allergy in the Th2-prone Brown Norway rat C. Frieke Kuper a,∗, Rob H. Stierum a, Andre Boorsma a,b, Marcel A. Schijf a, Menk Prinsen a, Joost P. Bruijntjes a, Nanne Bloksma c, Josje H.E. Arts a a TNO, Quality of Life, Zeist, The Netherlands b Department of Health Risk Analysis and Toxicology, Maastricht University, Maastricht, The Netherlands c Subfaculty of Biology, Faculty of Science, Utrecht University, The Netherlands Received 30 October 2007; received in revised form 21 December 2007; accepted 21 January 2008 Available online 2 February 2008 Abstract All LMW respiratory allergens known to date can also induce skin allergy in test animals. The question here was if in turn skin allergens can induce allergy in the respiratory tract. Respiratory allergy was tested in Th2-prone Brown Norway (BN) rats by dermal sensitization with the contact allergen dinitrochlorobenzene (DNCB; 1%, day 0; 0.5%, day 7) and a head/nose-only inhalation challenge of 27 mg/m3 of DNCB (15 min, day 21), using a protocol that successfully identified chemical respiratory allergens. Skin allergy to DNCB was examined in BN rats and Th1-prone Wistar rats in a local lymph node assay followed by a topical patch challenge of 0.1% DNCB. Sensitization of BN rats via the skin induced DNCB-specific IgG in serum, but not in all animals, and an increased number of CD4+ cells in the lung parenchyma. Subsequent inhalation challenge with DNCB did not provoke apneas or allergic inflammation (signs of respiratory allergy) in the BN rats.
    [Show full text]
  • (Trouessart) and D. Farinae Hughes (Acari: Pyroglyphidae) Sensitivity in Patients with Allergic Rhinitis: a Comparative Study
    Systematic & Applied Acarology 23(2): 404–404 (2018) ISSN 1362-1971 (print); http://dx.doi.org/10.11158/saa.23.2.17 ISSN 2056-6069 (online) Erratum Correction: Evaluation of Dermatophagoides pteronyssinus (Trouessart) and D. farinae Hughes (Acari: Pyroglyphidae) sensitivity in patients with allergic rhinitis: a comparative study ERHAN ZEYTUN1*, SALİH DOĞAN1, EDHEM ÜNVER2 & FATİH ÖZÇİÇEK3 1 Department of Biology, Arts & Sciences Faculty, Erzincan University, Erzincan, Turkey 2 Department of Chest Disease, Erzincan University School of Medicine, Erzincan, Turkey 3 Department of Internal Medicine, Erzincan University School of Medicine, Erzincan, Turkey * Corresponding author: [email protected] The authors are sorry that they made a mistake in spelling the family name of the first author on line 4 of page 206 in Zeytun et al. (2018): EYTUN should be ZEYTUN. This type error is evident in the paper itself because the running title in the footer of page 207 has the correct name: “ZEYTUN ET AL.: SENSITIVITY TO HDMS IN PATIENTS WITH ALLERGIC RHINITIS”. Reference Zeytun1, E., Doğan, S., Ünver, E. & Özçiçek, F. (2018) Evaluation of Dermatophagoides pteronys- sinus (Trouessart) and D. farinae Hughes (Acari: Pyroglyphidae) sensitivity in patients with allergic rhinitis: a comparative study. Systematic & Applied Acarology, 23(2), 206–215. https://doi.org/10.11158/saa.23.2.2 Published: 22 Feb. 2018 1. Not “Eytun” 404 © Systematic & Applied Acarology Society Systematic & Applied Acarology 23(2): 206–215 (2018) ISSN 1362-1971 (print) http://doi.org/10.11158/saa.23.2.2
    [Show full text]
  • Culicoides Obsoletus Allergens for Diagnosis of Insect Bite Hypersensitivity in Horses
    Culicoides obsoletus allergens for diagnosis of insect bite hypersensitivity in horses Nathalie M.A. van der Meide Thesis committee Promotor Prof. dr. ir. H. F. J. Savelkoul Professor of Cell Biology and Immunology Wageningen University Co-promotor Dr. E. Tijhaar Assistent professor, Cell Biology and Immunology Group Wageningen University Other members Prof. dr. ir. B. Kemp, Wageningen University, The Netherlands Dr. B. Wagner, Cornell University, Itaca, USA Prof. dr. V.P.M.G. Rutten, Utrecht University, The Netherlands Prof. dr. R. Gerth van Wijk, Erasmus MC Rotterdam, The Netherlands This research was conducted under the auspices of the Graduate School of the Wageningen Institute of Animal Sciences Culicoides obsoletus allergens for diagnosis of insect bite hypersensitivity in horses Nathalie M.A. van der Meide Thesis Submitted in fulfilment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. dr. M. J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Friday 13 September 2013 at 1.30 p.m. in the Aula Nathalie M.A. van der Meide Culicoides obsoletus allergens for diagnosis of insect bite hypersensitivity in horses PhD Thesis, Wageningen University, Wageningen, NL (2013) With references, with summaries in Dutch and English ISBN: 978-94-6173-669-7 Contents Chapter 1 General introduction 7 Chapter 2 Culicoides obsoletus extract relevant for diagnostics of insect bite hypersensitivity in horses 45 Chapter 3 Seasonal
    [Show full text]
  • Cscl Specimen Collection Guide 1
    CSCL SPECIMEN COLLECTION GUIDE 1 Test Name Alternative Name Specimen Special Requirements ? CSF β-transferrin, tau transferrin Nasal or ear secretions ?Parasite Parasitosis Parasite in a pottle 1,25 dihydroxy cholecalciferol 1,25 diOH Vit D, 1,25 dihydroxy Vit D, Calcitriol Yellow Protect from light with tinfoil. 1,25 Di-OH Vit D 1,25 Dihydroxy Vitamin D, 1,25 diOH cholecalciferol, Calcitriol Yellow Protect from light with tinfoil. 11 Deoxycortisol Metyrapone test Yellow Take dedicated tube. State whether pre or post metyparone sample. 17 hydroxysteroids 17 ketosteroids, Urine cortisol Urine - random or 24hr plain collection 17 β estradiol - sensitive Yellow Preferred sample collected between 0800-1000. 17-Ketosteroid - refer to Cortisol 17OH Progesterone Yellow Note pre and post dose on CHL sticker if this test is done with a synacthen test. 17-OH Progesterone/P4 17α hydroxy progesterone Yellow Note pre and post dose on CHL sticker if this test is done with a synacthen test. 17α hydroxy progesterone 17-OH progesterone/P4 Yellow Note pre and post dose on CHL sticker if this test is done with a synacthen test. 17β Oestradiol Estradiol, Estrogen, E2, Oestradiol Yellow 17β Oestradiol - Sensitive Estradiol, Estrogen, E2, Oestradiol Yellow NOTE: Sensitive assay no longer available at CHL. OES done at CSCL instead. 25-hydroxy cholecalciferol Vitamin D, Cholecalciferol, 25-OH vitamin D Yellow 25-hydroxy vitamin D 25-OH vitamin D, cholecalciferol Yellow 25-OH cholecalciferol 25-hydroxy vitamin D Yellow 5 hydoxy tryptamine - see 5HT 5HIAA HIAA Quantitation, 5-hydroxy indole acetic acid, serotonin metabolites, 24hr Urine bottle (acid or plain) or random collection (>5mL) Medication history must be noted on request form.
    [Show full text]
  • Skin Allergy Testing
    CONSENT WHAT TO EXPECT AT WELLINGTON SCL Allergens used in Skin Prick Testing, including the positive Our experienced staff are fully trained in the performance of these control are considered to be medicines therefore required tests but the ordering doctor remains responsible for explaining the to be registered in New Zealand. Unfortunately the results. Histamine control and some allergens available are not currently registered, therefore come under Section 29 of Once your arm (or back) is prepared a small amount of each allergen the Medicines Act. is applied and pricked. Your immune system will interact with the allergen over the next 15 minutes and produce an itchy wheal (like Under the Medicines Act 1981, the pharmaceutical a mosquito bite) if you have sensitisation to that product. You must company selling the medicine has to inform the Director not scratch the wheals while they develop as this may change their Skin Allergy of Health that it has sold the medicine to the laboratory, intensity. and has to name the doctor and yourself, describe the medicines and say where and when the medicine was sold. Some medications, such as antihistamines and antidepressants may This means we may have to supply these particulars to the interfere with the results. Please let us know what medications are Testing pharmaceutical company. being taken before booking the appointment. Negative testing does not guarantee there is no allergy but makes an allergic cause less likely. Further tests may be required to find I the cause of the problem or challenge testing may be required. Our have received enough information to provide my consent Immunopathologists also work as Allergists and welcome contact for the performance of the Skin Allergy Test.
    [Show full text]
  • Opinion on Allergy Alert Test (AAT) As a Proof-Of-Concept Study ______
    SCCS/1607/19 Final Opinion Scientific Committee on Consumer Safety SCCS OPINION ON Allergy Alert Test (AAT) as a proof-of-concept study The SCCS adopted the final Opinion by written procedure on 10 September 2019 SCCS/1607/19 Final Opinion Opinion on Allergy Alert Test (AAT) as a proof-of-concept study _________________________________________________________________________________________________________________ ACKNOWLEDGMENTS SCCS members listed below are acknowledged for their valuable contribution to the finalisation of this Opinion. For the preliminary and the final versions SCCS members Dr U. Bernauer Dr L. Bodin Prof. Q. Chaudhry (SCCS Chair) Prof. M. Dusinska Dr J. Ezendam Dr E. Gaffet Prof. C. L. Galli Dr B. Granum Prof. E. Panteri Prof. V. Rogiers (SCCS Vice-Chair) Dr Ch. Rousselle Dr M. Stepnik Prof. T. Vanhaecke Dr S. Wijnhoven SCCS external experts Dr A. Koutsodimou Dr A. Simonnard Prof. W. Uter (Rapporteur) All Declarations of Working Group members are available on the following webpage: http://ec.europa.eu/health/scientific_committees/experts/declarations/sccs_en.htm This Opinion has been subject to a commenting period of a minimum eight weeks after its initial publication (from 13 May 2019 until 12 July 2019). Comments received during this time period were considered by the SCCS. For this Opinion, comments received resulted in the following main changes: SCCS comments in sections 3.2.4, 3.3.2.1. and 3.3.2.5. These changes are not impacting the discussion and conclusion parts that remain unchanged. 2 SCCS/1607/19 Final Opinion Opinion on Allergy Alert Test (AAT) as a proof-of-concept study _________________________________________________________________________________________________________________ 1.
    [Show full text]
  • Skin Allergy Test Information for Patients, Relatives and Carers
    Lung Function Laboratory Skin allergy test Information for patients, relatives and carers This leaflet has been designed to give you information about skin allergy test and answers some of the questions that you or those who care for you may have. It is not meant to replace the discussion between you and your medical team but aims to help you understand more about what is discussed. If you have any questions about the information below, please contact us. Introduction The skin allergy test or skin prick test is a diagnostic test that investigates the immediate response of your body when exposed to specific allergens. This can aid your doctor in diagnosing and treating the symptoms you may be suffering from. What to expect on the day The test will be performed by putting drops of liquid allergen on the skin of your forearm and then lightly pricking the skin to see if a reaction occurs. Once the reactions have had a sufficient time to develop they will then be measured with the entire process taking roughly 30 minute in duration. During this time you may experience some minor swelling and itchiness around the test sites which should subside prior to you leaving the lung function department. Allergens we test for Air-borne allergens are transported through the air and into the nose, which can cause an allergic reaction. We test the most common allergy triggers from within and around your home environment. These include animal fur, feathers, tree and flower pollen, mould spores and house dust mite. We test 10 allergens as well as two control solutions.
    [Show full text]
  • Sensitivity to House Dust Mites Allergens in Patients with Allergic
    34 Original Investigation / Özgün Araştırma Sensitivity to House Dust Mites Allergens in Patients with Allergic Asthma in Erzincan Province, Turkey Erzincan’da Alerjik Astımlı Hastaların Ev Tozu Akar Alerjenlerine Karşı Duyarlılığı Erhan Zeytun1, Salih Doğan1, Fatih Özçiçek2, Edhem Ünver3 1Department of Biology, Erzincan University Faculty of Arts and Sciences, Erzincan, Turkey 2Department of Internal Medicine, Erzincan University School of Medicine, Erzincan, Turkey 3Department of Chest Disease, Erzincan University School of Medicine, Erzincan, Turkey ABSTRACT Objective: To investigate the sensitivity of allergic asthma (AA) patients to house dust mites (HDM) by conducting skin tests, measuring total and specific IgE antibodies toDermatophagoides pteronyssinus and D. farinae mites, and examining HDM fauna in patients’ homes. Methods: The study included 25 patients with AA and 31 healthy controls, who were challenged with Der p and Der f allergens; serum levels of allergen-specific lgE and total IgE were measured. Dust samples were collected from the homes of all participants, and mite species and the number of mites per gram of dust were investigated. Results: D. pteronyssinus was found in the homes of 94.7% patients with positive Der p reactions in the skin test (p<0.001). D. farinae was found in the homes of 22.2% patients with positive Der f reactions in the skin test (p>0.05). D. pteronyssinus-specific IgE was detected in 75% patients in whose homes D. pteronyssinus was also found, while D. farinae-specific IgE was detected in 16.6% patients in whose homesD. farinae was also found. Conclusion: A part of AA patients residing in Erzincan are sensitive to HDM allergens, and high numbers of mites leading to allergic sensi- tization are found in their homes.
    [Show full text]
  • Atopic Dermatitis with Possible Polysensitization and Monkey Esophagus Reactivity
    www.najms.org North American Journal of Medical Sciences 2010 July, Volume 2. No. 7. Case Report OPEN ACCESS Atopic dermatitis with possible polysensitization and monkey esophagus reactivity Ana Maria Abreu Velez, MD, Ph.D1, Michael S. Howard, MD,1 Bruce R. Smoller MD 2 1Georgia Dermatopathology Associates, Atlanta, Georgia, USA. 2Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. Citation: Abreu Velez AM, Howard MS, Smoller BR. Atopic dermatitis with possible polysensitization and monkey esophagus reactivity. North Am J Med Sci 2010; 2: 336-340. Availability: www.najms.org ISSN: 1947 – 2714 Abstract Context: Atopic dermatitis is a chronic inflammatory skin disease resulting from interactions between environmental and genetic factors. Recent studies link atopic dermatitis with asthma and with eosinophilic esophagitis. Case Report: Based on this association, we investigated by indirect immunofluorescence the immunoreactivity patterns on monkey esophagus substrate utilizing the serum of a patient with severe atopic dermatitis. We also examined the patient’s skin biopsy by H&E histology and immunohistochemistry. We detected strong deposits of albumin, IgE, IgG, IgD, IgA, Complement/C1q and mast cell tryptase in multiples structures of the skin, as well as a broad pattern of intraepithelial staining on monkey esophagus. Strong staining positivity was also detected within the inflammatory infiltrate around the upper dermal vessels, as well as additional positive staining for the human leukocyte antigen system antigens DR DP and DQ. Conclusion: Our findings demonstrate that there could be an indication for testing patients with severe atopic dermatitis for autoreactivity to filaggrin (anti-keratin antibodies) utilizing monkey esophagus.
    [Show full text]
  • Medical Review
    Publishing Sector of the Society of Physicians of Vojvodina of the Medical Society of Serbia, Novi Sad, Vase Stajica 9 MEDICAL REVIEW JOURNAL OF THE SOCIETY OF PHYSICIANS OF VOJVODINA OF THE MEDICAL SOCIETY OF SERBIA THE FIRST ISSUE WAS PUBLISHED IN 1948 Editor-in-Chief LJILJA MIJATOV UKROPINA Assistant to the Editor-in-Chief for Clinical Branches: PETAR SLANKAMENAC Assistant to the Editor-in-Chief for Imaging Methods: VIKTOR TILL Assistants to the Editor-in-Chief SONJA LUKAČ ŽELJKO ŽIVANOVIĆ EDITORIAL BOARD OKAN AKHAN, Ankara MIROSLAV MILANKOV, Novi Sad ANDREJ ALEKSANDROV, Birmingham OLGICA MILANKOV, Novi Sad STOJANKA ALEKSIĆ, Hamburg IGOR MITIĆ, Novi Sad VLADO ANTONIĆ, Baltimor NADA NAUMOVIĆ, Novi Sad ITZHAK AVITAL, Bethesda AVIRAM NISSAN, Ein Karem KAREN BELKIĆ, Stockholm JANKO PASTERNAK, Novi Sad JEAN-PAUL BEREGI, Lille Cedex ĐORĐE PETROVIĆ, Novi Sad HELENA BERGER, Ljubljana LJUBOMIR PETROVIĆ, Novi Sad KSENIJA BOŠKOVIĆ, Novi Sad TOMISLAV PETROVIĆ, Novi Sad VLADIMIR ČANADANOVIĆ, Novi Sad MIHAEL PODVINEC, Basel IVAN DAMJANOV, Kansas City JOVAN RAJS, Danderyd JADRANKA DEJANOVIĆ, Novi Sad TATJANA REDŽEK MUDRINIĆ, Novi Sad OMER DEVAJA, Meidstone PETAR E. SCHWARTZ, New Haven RADOSLAVA DODER, Novi Sad MILAN SIMATOVIĆ, Banja Luka PETAR DRVIŠ, Split TOMAŠ SKRIČKA, Brno ZORAN GOJKOVIĆ, Novi Sad PETAR SLANKAMENAC, Novi Sad IRENA HOČEVAR BOLTEŽAR, Ljubljana EDITA STOKIĆ, Novi Sad DEJAN IVANOV, Novi Sad ALEXANDER STOJADINOVIĆ, Glen Alen MARIJA JEVTIĆ, Novi Sad MILANKA TATIĆ, Novi Sad MARINA JOVANOVIĆ, Novi Sad VIKTOR TILL, Novi Sad ZORAN KOMAZEC,
    [Show full text]
  • Asia Pacific Educational & Teaching Material Doi: 10.5415/Apallergy.2011.1.1.43 Allergy Asia Pac Allergy 2011;1:43-49
    pISSN 2233-8276 · eISSN 2233-8268 Asia Pacific Educational & Teaching Material doi: 10.5415/apallergy.2011.1.1.43 allergy Asia Pac Allergy 2011;1:43-49 Hypersensitivity manifestations to the fruit mango Richa Sareen and Ashok Shah* Department of Respiratory Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi 110 007, India The objectives of this study are 1) To review the published data and document the current knowledge on allergic manifestations to the fruit mango 2) To highlight the two distinct clinical presentations of hypersensitivity reactions caused by mango 3) To discuss the role of cross-reactivity 4) To increase awareness of potentially life threatening complications that can be caused by allergy to mango. An extensive search of the literature was performed in Medline/PubMed with the key terms “mango”, “anaphylaxis”, “contact dermatitis”, “cross-reactivity”, “food hypersensitivity”, “oral allergy syndrome” and “urticaria”. The bibliographies of all papers thus located were searched for further relevant articles. A total of 17 reports describing 22 patients were documented, including ten patients with immediate hypersensitivity reaction and twelve patients with delayed hypersensitivity reaction to mango. Ten of these patients (four with immediate reaction; six with delayed reaction) were from geographical areas cultivating mango, whereas twelve patients (six with immediate reaction; six with delayed reaction) were from the countries where large scale mango cultivation does not occur. The clinical features, pathogenesis and diagnostic modalities of both these presentations are highlighted. The fruit mango can cause immediate and delayed hypersensitivity reactions, as also “oral allergy syndrome”. Although rare, it can even result in a life threatening event.
    [Show full text]